Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Therapeutics, Inc. - Common Stock
(NQ:
AXSM
)
90.73
+0.99 (+1.10%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Therapeutics, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
19
20
Next >
Analyst Expectations for Axsome Therapeutics's Future
March 01, 2023
Via
Benzinga
Axsome Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
March 01, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics (AXSM) Q4 2022 Earnings Call Transcript
February 27, 2023
AXSM earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why Axsome Therapeutics (AXSM) Shares Are Trading Higher
February 27, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher by 3.22% to $63.02 Monday morning after the company reported mixed fourth-quarter financial results. What Happened?
Via
Benzinga
Axsome Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
February 27, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics's Earnings: A Preview
February 24, 2023
Via
Benzinga
The Latest Analyst Ratings for Axsome Therapeutics
January 30, 2023
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $1,900 Today
January 09, 2023
Via
Benzinga
A New Bull Market Is in Sight: 3 Stocks to Buy Sooner Rather Than Later
February 27, 2023
All three of these stocks have impressive growth prospects.
Via
The Motley Fool
Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe
February 22, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Long Term Investor Alert: Lawsuit Against Directors Filed
February 17, 2023
San Diego, CA -- (SBWIRE) -- 02/17/2023 -- An investor in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) filed a lawsuit against certain directors of Axsome Therapeutics, Inc. over alleged breaches...
Via
SBWire
Meta Platforms Layoffs 2023: What to Know as Facebook Preps More Job Cuts
February 13, 2023
Meta Platforms (META) layoffs are a hot topic among traders Monday as the Facebook parent company reportedly considering more job cuts.
Via
InvestorPlace
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
February 13, 2023
Axsome Therapeutics (AXSM) stock is taking a beating on Monday as rival Teva Pharmaceutical (TEVA) prepares a generic depression drug.
Via
InvestorPlace
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling
February 13, 2023
The company only just gained approval for its depression drug in August.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 13, 2023
Via
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
February 12, 2023
These companies could grow in prominence in the coming years.
Via
The Motley Fool
3 Surefire Growth Stocks You Can Buy Right Now
February 11, 2023
Maybe there's no such thing as a sure thing. But these stocks could come close.
Via
The Motley Fool
3 Stocks That Could Soar Whether There's a New Bull Market or Not
February 10, 2023
These stocks could enjoy their own bull markets regardless of what the overall market does.
Via
The Motley Fool
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
January 31, 2023
Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The Ultimate Growth Stocks to Buy With $300 Right Now
January 29, 2023
These three companies should deliver inflation-busting long-term growth.
Via
The Motley Fool
2 Promising New Growth Stocks to Watch in 2023
January 23, 2023
These stocks have plenty of room to run.
Via
The Motley Fool
3 Unstoppable Stocks to Keep Buying in 2023
January 19, 2023
These companies have what it takes to drive long-term share performance.
Via
The Motley Fool
2 Stocks That Could Double Your Money in 2023
January 07, 2023
These biotechs could crush the market, but there is more to the story.
Via
The Motley Fool
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.
January 07, 2023
These stocks look cheap if you take a long-term view.
Via
The Motley Fool
5 Top Stocks to Buy to Start the New Year Right
January 05, 2023
This may be the easiest of your New Year's resolutions. And it could pay off big.
Via
The Motley Fool
How Is The Market Feeling About Axsome Therapeutics?
January 03, 2023
Axsome Therapeutics's (NASDAQ:AXSM) short percent of float has fallen 7.06% since its last report. The company recently reported that it has 7.37 million shares sold short, which is 20.81% of all...
Via
Benzinga
100 Best Stocks Of 2022: Fossil Fuel Ignites, Solar Shines, Meds Make Miracles
December 30, 2022
Energy and medical plays top the 100 Best Stocks of 2022. It makes sense, given world events that shifted the first-quarter playing field.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.